By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eiger Biopharma 

Palo Alto  California    U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Eiger Biopharma Provides Corporate Update And Reports First Quarter 2016 Financial Results 5/17/2016 6:57:34 AM
Eiger Biopharma Announces First Patient Dosed In Phase 2 Multiple Ascending Dose Study Of Subcutaneous Exendin (9-39) In Patients With Hypoglycemia Post-Gastric Bypass Surgery 5/10/2016 6:21:34 AM
Eiger Biopharma Strengthens Senior Management Team With Announcement Of Debra Odink, PhD As Senior Vice President Of Technical Operations 5/3/2016 6:38:00 AM
Eiger Biopharma Announces License Of Worldwide Rights To Pegylated Interferon Lambda-1a From Bristol-Myers Squibb (BMY) 4/21/2016 6:02:29 AM
Eiger Biopharma Strengthens Board Of Directors With Addition Of Industry Veteran Charles J. "Chuck" Bramlage 4/4/2016 8:35:47 AM
Eiger Biopharma Announces Abstracts And Presentations Of Lonafarnib Data In Hepatitis Delta At The European Association For The Study Of The Liver (EASL) Meeting 3/30/2016 6:55:02 AM
Eiger Biopharma Granted Orphan Medicinal Product Designation For Ubenimex In Pulmonary Arterial Hypertension By European Medicines Agency 3/28/2016 6:13:30 AM
Eiger Biopharma Closes Merger With Celladon (CLDN) 3/23/2016 6:11:06 AM
Eiger Biopharma Announces Completion Of Enrollment Of Phase 2 LOWR HDV - 4 (LOnafarnib With Ritonavir In Hepatitis Delta Virus - 4) Study At Hannover Medical School 3/14/2016 6:17:24 AM
Eiger Biopharma To Participate In Cowen and Company 2016 Health Care Conference 2/29/2016 9:55:26 AM